Methotrexate and low-dose prednisolone downregulate osteoclast function by decreasing receptor activator of nuclear factor-κβ expression in monocytes from patients with early rheumatoid arthritis.

about

Methotrexate and low-dose prednisolone downregulate osteoclast function by decreasing receptor activator of nuclear factor-κβ expression in monocytes from patients with early rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q41687198

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Methotrexate and low-dose pred ...... th early rheumatoid arthritis.

@en

type

Item

label

Methotrexate and low-dose pred ...... th early rheumatoid arthritis.

@en

prefLabel

Methotrexate and low-dose pred ...... th early rheumatoid arthritis.

@en

P1476

Methotrexate and low-dose pred ...... th early rheumatoid arthritis.

@en

P2093

Inês Pedro Perpétuo

http://www.w3.org/2001/XMLSchema#string

Raquel Campanilho-Marques

http://www.w3.org/2001/XMLSchema#string

P2860

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation

Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.

Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states.

Surface RANKL of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption.

Monocyte scintigraphy in rheumatoid arthritis: the dynamics of monocyte migration in immune-mediated inflammatory disease.

Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis.

Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis.

Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils.

P304

e000365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/RMDOPEN-2016-000365

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28955481

http://www.w3.org/2001/XMLSchema#string

P932

5604603

http://www.w3.org/2001/XMLSchema#string